End of year Oncopeptalks published

In the last episode of the year for Oncopeptalks, Sofia Heigis, CEO and David Augustsson, IR Director, cover topics such as when we can expect a decision regarding Oncopeptides’ appeal in the U.S., sales in Europe in 2024 and beyond as well as share some highlights from this year’s ASH meeting in San Diego.

Watch the video below! (Also available in Swedish, with similar content)

If you have any questions or issues that you’d like to have addressed in future editions, reach out to David at david.augustsson@oncopeptides.com.